Abstract
Parkinson’s disease is the second most common neurodegenerative disease, treatment consists of a combination of drugs, physiotherapy and advanced therapies, which seek to improve the quality of life of these patients, such as deep brain stimulation. Although anesthetic management is varied, it has been considered that the most appropriate technique taking into account the risks / benefits is the one consisting of asleep / awake / asleep, since it allows the interaction of the patient with the multidisciplinary team to guarantee correct placement of the stimulation electrodes. Due to the studies carried out for the use of anesthetic drugs, the use of propofol and dexmedetomidine has been implemented, not finding significant differences when choosing one or the other drug, but showing positive effects in improving the quality of life of these patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
